Proton magnetic resonance spectroscopy in multiple sclerosis
- PMID: 19064199
- PMCID: PMC2615006
- DOI: 10.1016/j.nic.2008.08.002
Proton magnetic resonance spectroscopy in multiple sclerosis
Abstract
Proton magnetic resonance spectroscopy ((1)H-MRS) provides tissue metabolic information in vivo. This article reviews the role of MRS-determined metabolic alterations in lesions, normal-appearing white matter, gray matter, and spinal cord in advancing our knowledge of pathologic changes in multiple sclerosis (MS). In addition, the role of MRS in objectively evaluating therapeutic efficacy is reviewed. This potential metabolic information makes MRS a unique tool to follow MS disease evolution, understand its pathogenesis, evaluate the disease severity, establish a prognosis, and objectively evaluate the efficacy of therapeutic interventions.
Figures
References
-
- Rovaris M, Comi G, Filippi M. The role of non-conventional MR techniques to study multiple sclerosis patients. J Neurol Sci. 2001 May 1;186 Suppl 1:S3–9. - PubMed
-
- Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol. 1998 Jan;43(1):56–71. - PubMed
-
- Wolinsky JS, Narayana PA. Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain. Curr Opin Neurol. 2002 Jun;15(3):247–251. - PubMed
-
- Gonzalez-Toledo E, Kelley RE, Minagar A. Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis. Neurol Res. 2006 Apr;28(3):280–283. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
